Team-BHP > Shifting gears
Register Team-BHP FAQ New Topics New Posts

Thread Tools Search this Thread
Old 26th March 2020, 14:34   #1
Distinguished - BHPian
laluks's Avatar
Join Date: Sep 2008
Location: Bangalore
Posts: 6,492
Thanked: 14,393 Times
Default Combating the coronavirus pandemic: Bosch develops rapid test for Covid-19

Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours. The test for COVID-19 can help medical facilities make fast diagnoses and play a part in containing the coronavirus pandemic.

The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch抯 new, fully automated rapid test for COVID-19 can help medical facilities such as doctors?offices, hospitals, laboratories, and health centers make fast diagnoses.

The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. ?i>We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,?says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH.

Faster certainty, slower spread

Bosch Vivalytic device
Name:  BoschVivalyticAnalyserKartuschen16x9_res_800x450.jpg
Views: 398
Size:  25.6 KB

Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours ?measured from the time the sample is taken to the time the result arrives. Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time. It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result. ?b>Time is of the essence in the fight against coronavirus. Reliable, rapid diagnosis directly on site with no back and forth ?that is the great advantage of our solution, which we see as another example of technology that is 慖nvented for life,挃 Denner says.

Bosch抯 rapid test is one of the world抯 first fully automated molecular diagnostic tests that can be used directly by all medical institutions. What抯 more, it allows a single sample to be tested not just for COVID-19 but also for nine other respiratory diseases, including influenza A and B, simultaneously. 揟he special feature of the Bosch test is that it offers differential diagnosis, which saves doctors the additional time needed for further tests. It also provides them with a reliable diagnosis quickly so they can then begin suitable treatment faster,?says Marc Meier, president of Bosch Healthcare Solutions GmbH. The newly developed test will be available in Germany starting in April, with other markets in Europe and elsewhere to follow.

Bosch抯 rapid COVID-19 test is the result of collaboration between the company抯 Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company Randox Laboratories Ltd. 揟ogether with our partner Randox, we have succeeded in developing this innovative rapid test within a very short time frame, and we are now in a position to offer it to the market. The Bosch Vivalytic analysis device evaluates the test safely and reliably directly in the hospital, in the lab, or in the doctor抯 office, guaranteeing the best possible protection for patients and medical staff,?Meier says. The company is currently examining how it can help doctors and nursing staff in medical facilities such as the Robert Bosch Hospital get tested promptly so they can be fit to work for as long as possible ?with no risk of infecting others.

Up to 1,000 tests per day on just 100 devices

Easy application at the point of care

In various laboratory tests with SARS-CoV-2, the Bosch test delivered results with an accuracy of over 95 percent. The rapid test meets the quality standards of the World Health Organization (WHO). A sample is taken from the patient抯 nose or throat using a swab. Then the cartridge, which already contains all the reagents required for the test, is inserted into the Vivalytic device for analysis. During the analysis, medical staff can devote themselves to other tasks, for example treating patients. The Vivalytic analyzer is designed to be so user-friendly that even medical personnel who have not been specially trained on it can reliably perform the test.

Some further news links

Last edited by laluks : 26th March 2020 at 14:56.
laluks is offline   (12) Thanks

Most Viewed

Copyright ?000 - 2020,
Proudly powered by E2E Networks